Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion type Assertion NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_head.
- NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion description "[LOX-1 is increasingly viewed as a vascular disease biomarker and a potential therapeutic target in heart attack and stroke prevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_provenance.
- NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion evidence source_evidence_literature NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_provenance.
- NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion SIO_000772 18092947 NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_provenance.
- NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion wasDerivedFrom befree-2016 NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_provenance.
- NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_assertion wasGeneratedBy ECO_0000203 NP646218.RAaH6qOaSXvWMd7Ga1jcoj8XT-EYl3r7OFPwNbLdRljqk130_provenance.